Case report of actinomycotic liver abscess following COVID-19 infection

• Published in: Annals of medicine and surgery 2022-10, Vol.82, p.104525-104525, Article 104525
• Main Authors: Lévay, Klára, Daradics, Noémi, Horváth, Tibor, Kovács, Tibor, Fülöp, András, Oláh, Attila, Szijártó, Attila
• Format: Article
• Language: English
• Subjects: Actinomycosis; Case Report; Drainage; Liver abscess; Opportunistic infection; SARS-CoV-2
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1016/j.amsu.2022.104525

In the last few years, the novel coronavirus, named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), generated a large health care problem worldwide. Due to the immunomodulation effect of the virus the number of opportunistic infections has also increased. We present the unique case of a patient who was diagnosed with an actinomycotic liver abscess after coronavirus disease 2019 (COVID-19) without the presence of any chronic disease or mucosal injury. According to the results of the computer tomography (CT scan) and the liver biopsy, the patient was treated with antibiotics and ultrasound-guided drainage. With this case we would like to draw attention to the possible occurrence of liver abscesses caused by an opportunistic pathogen following COVID-19. •SARS-CoV-2 is an acute respiratory infection, that could result immune dysregulation.•Immunocompromised patients have a higher risk for opportunistic infections (e.g. actinomycosis).•Actinomycosis could result in liver abscess, which is a rare type of the liver abscesses.•Actinomycosis followed by COVID-19 infection disease could be a post-COVID syndrome.